Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Single Patient Drug Leaflet Logical, Complicated To Achieve - Woodcock

Executive Summary

FDA officials are leaning toward a single document to inform patients about their medications, but whether and how that can be accomplished remain unanswered questions

You may also be interested in...



Oral Contraceptive Labeling Likely To Become More Graphic

FDA is nearing completion of guidance on labeling for combined oral contraceptives with an eye toward improving communication with more visual presentations rather than relying on prose.

One-Page MedGuide For Long-acting Opioids Sets Stage For Retooling MedGuide Format

The single-page format could serve as a template as FDA tries to simplify patient information that accompanies prescription drugs.

FDA's Chicken Or Egg Question For Pharmacy Leaflets: Should Benefit Or Risk Come First?

FDA will look at which should come first – benefits or risks – when it studies patients' response to three one-page prototypes of patient medication information.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS051551

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel